EUA
SARS-CoV-2 RT-PCR Assay
FDA Emergency Use Authorization · Stanford Health Care Clinical Virology Laboratory · Nov 24, 2020
Key facts
| Product | SARS-CoV-2 RT-PCR Assay |
|---|---|
| Company | Stanford Health Care Clinical Virology Laboratory |
| Product type | Real-time RT-PCR, Home Collection, Single Target |
| Date | Nov 24, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: